Dickinson Andrew D 4

What Happened
Andrew D. Dickinson, Chief Financial Officer of Gilead Sciences (GILD), sold 3,000 shares in an open-market transaction on March 16, 2026, at $144.23 per share, for total proceeds of $432,690. This was a sale (insider disposition) rather than a purchase.

Key Details

• Transaction date: 2026-03-16
• Transaction type/code: Open-market sale (S)
• Price per share: $144.23
• Shares sold: 3,000
• Total proceeds: $432,690
• Shares owned after transaction: Not specified in the provided filing excerpt
• Footnote: Trade was made pursuant to a Rule 10b5-1 trading plan adopted August 29, 2024 (F1)
• Filing date/timeliness: Form 4 filed 2026-03-17 reporting the 2026-03-16 transaction — appears timely; no late-filing indication in the excerpt

Context
The sale was executed under a pre-established Rule 10b5-1 plan, which allows insiders to sell shares according to a preset schedule and can limit the inference that the trade reflects current, nonpublic company knowledge. Sales under 10b5-1 plans are often routine and should not be interpreted on their own as a definitive signal about management’s view of the company.